Coordinatore | EUROPABIO - The European Association of Bioindustries
Organization address
address: Avenue de l'Armee 6 contact info |
Nazionalità Coordinatore | Belgium [BE] |
Totale costo | 2˙809˙777 € |
EC contributo | 1˙995˙798 € |
Programma | FP7-KBBE
Specific Programme "Cooperation": Food, Agriculture and Biotechnology |
Code Call | FP7-KBBE-2012-6-singlestage |
Funding Scheme | CSA-CA |
Anno di inizio | 2012 |
Periodo (anno-mese-giorno) | 2012-08-01 - 2015-07-31 |
# | ||||
---|---|---|---|---|
1 |
EUROPABIO - The European Association of Bioindustries
Organization address
address: Avenue de l'Armee 6 contact info |
BE (BRUSSELS) | coordinator | 505˙028.75 |
2 |
POYRY MANAGEMENT CONSULTING OY
Organization address
address: JAAKONKATU 3 contact info |
FI (VANTAA) | participant | 266˙162.25 |
3 |
DECHEMA GESELLSCHAFT FUER CHEMISCHE TECHNIK UND BIOTECHNOLOGIE E.V.
Organization address
address: Theodor-Heuss-Allee 25 contact info |
DE (FRANKFURT) | participant | 254˙281.00 |
4 |
Nome Ente NON disponibile
Organization address
address: Avenue E Van Nieuwenhuyse 4 contact info |
BE (Brussels) | participant | 225˙139.00 |
5 |
NOVA-INSTITUT FUR POLITISCHE UND OKOLOGISCHE INNOVATION GMBH
Organization address
address: Chemiepark Knapsack Industriestrasse contact info |
DE (Huerth) | participant | 211˙013.00 |
6 |
BVBA CLEVER CONSULT
Organization address
address: BEEKSTRAAT 21 contact info |
BE (MEISE WOLVERTEM) | participant | 157˙824.50 |
7 |
NEDERLANDSE ORGANISATIE VOOR TOEGEPAST NATUURWETENSCHAPPELIJK ONDERZOEK TNO
Organization address
address: Schoemakerstraat 97 contact info |
NL (DEN HAAG) | participant | 103˙790.00 |
8 |
PNO CONSULTANTS LIMITED
Organization address
address: EARL ROAD 1 THE COURTYARD contact info |
UK (CHEADLE HULME) | participant | 66˙340.00 |
9 |
ASSOCIATION INDUSTRIES ET AGRORESSOURCES
Organization address
address: Boulevard Brossolette 50-52 contact info |
FR (LAON Cedex) | participant | 61˙551.00 |
10 |
CIAOTECH Srl
Organization address
address: Via Palestrina 25 contact info |
IT (Rome) | participant | 42˙265.00 |
11 |
KNOWLEDGE TRANSFER NETWORK LIMITED
Organization address
address: BAILEY HOUSE 4-10 BARTTELOT ROAD contact info |
UK (HORSHAM) | participant | 41˙011.59 |
12 |
CHEMISTRY INNOVATION LIMITED
Organization address
address: BURLINGTON HOUSE PICADILLY contact info |
UK (LONDON) | participant | 34˙641.91 |
13 |
PNO INNOVATION
Organization address
address: EXCELSIORLAAN 51 contact info |
BE (ZAVENTEM) | participant | 26˙750.00 |
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
'The project goal is to draw-up a blueprint document of recommendations for overcoming the innovation hurdles within a selection of targeted business market segments that can make a major contribution to an accelerated take-up of industrial biotechnology (IB) into the market place. This will involve: - Analysis of existing knowledge bank relating to market, research and institutional barriers hindering uptake of IB technology innovations into the market place - Engagement with a broad range of stakeholders across the full multidisciplinary IB spectrum to update, develop and validate these innovation barriers to market entry - Formulation of a roadmap of action plans and policy recommendations for accelerated uptake of IB into a number of targeted product segment areas
Bio-TIC will compile an in-depth preparation of three “interim roadmaps” comprising market projections, R&D priorities and non-technological barriers to IB market entry. These will act to guide and facilitate a series of convened stakeholder workshops at both national and European level for a full discussion on innovation barriers, in order to validate and further elaborate more comprehensive roadmaps, while taking on board the totality of views from the diverse IB stakeholder base. Finally, the partners will collate and further refine the developed roadmaps into a joint European IB Roadmap and Policy recommendations document, with maximum stakeholder buy-in for wide dissemination and maximum impact. The project will be co-ordinated by EuropaBio- the European Association for Biotechnology Industries, who will also be joined by CEFIC, the European Chemical Industry Council, representing the European chemical industry. These will be joined in the consortium by a further 9 members incorporating innovation agencies, cluster organisations and private management consultancies; all of whom have many complementary skills and expertise and who have worked together in the past on similar initiatives.'
Using biotechnology in industrial processes is one of the most promising ways to reduce pollution, resource waste and costs while opening new product markets. An EU-funded study is identifying barriers to uptake in order to knock them down.
Biotechnology is the use of biological processes and living organisms in products and technologies, and industrial biotechnology (IB) applies it to industrial activities. The EU is moving forward in a dynamic way with the project http://www.industrialbiotech-europe.eu/ (BIO-TIC) to identify and overcome barriers to widespread market uptake of IB to increase competitiveness.
Scientists are focusing on the five product groups with the greatest potential for Europe and delivering recommendations for overcoming innovation hurdles. The product groups were chosen based on criteria relating to breakthrough potential, socioeconomic benefits and environmental impact.
Four of the five product areas (bio-surfactants, biofuels for transport, bioplastics and chemical precursors to other products) exploit biomass. The fifth product group turns carbon dioxide from fossil fuel combustion such as that in exhaust gases at power plants into novel products.
An in-depth review of the technological barriers affecting the five sectors demonstrated a large overlap among research and development needs of the five businesses studied. The single most important hurdle was the lack of cost competitiveness of EU IB-derived products.
Both in comparison to similar products by other providers elsewhere in the world and to petroleum-derived products, EU IB-derived products are prohibitively more expensive. This is largely due to market conditions, feedstock supply/price issues and lower yields of IB products.
A preliminary roadmap or set of recommendations to overcome the hurdles was developed as was a framework of definitions, units and standards to facilitate data collection and discussions. In addition, researchers prepared a data collection toolbox to assess the socioeconomic and environmental impact of IB. Finally, a partnering platform available on the website helps link stakeholders, promote funding opportunities, set up meetings and conduct job searches.
BIO-TIC is fostering a positive environment for IB innovation in Europe. A better competitive position and faster development of new products will increase jobs for EU citizens and reduce the environmental impact of their work.
Protecting the health of Europeans by improving methods for the detection of pathogens in drinking water and water used in food preparation
Read MoreBiological control manufacturers in Europe develop novel biological control products to support the implementation of Integrated Pest Management in agriculture and forestry
Read MoreConfronting the clinical relevance of biocide induced antibiotic resistance
Read More